Regen BioPharma, Inc., a publicly traded biotechnology company, has appointed Dr. Harry Lander president. Lander brings extensive experience as both a researcher and administrator to the company and has served in these positions at Cornell University and Sidra Medical and Research Centre in Qatar.
Regen Appoints President
Regen BioPharma, Inc., a publicly traded biotechnology company, has appointed Dr. Harry Lander president. Lander brings extensive experience as both a researcher and administrator to the company and has served in these positions at Cornell University and Sidra Medical and Research Centre in Qatar.
More from Business
More from Scrip
• By
Second quarter revenue and EPS beat consensus and BMS raised its 2025 revenue guidance, but after multiple recent Phase III failures, executives said the company is reviewing studies with near-term readouts.
• By
AbbVie now expects the two Humira successors to bring in $25bn this year. On its Q2 earnings call, the firm also pointed to strength in neuroscience, with 24% growth.
• By
Sales of Leqembi, Zurzuvae and Skyclarys contributed to Biogen’s sales and earnings guidance raise, positioning the company closer to potential growth.